Protonation equilibrium and lipophilicity of olamufloxacin (HSR-903), a newly synthesized fluoroquinolone antibacterial

By Sun J.   Sakai S.   Tauchi Y.   Deguchi Y.   Cheng G.   Chen J.   Morimoto K.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 56, Iss. 2, 2003-09 ,pp. : 223-229

Elsevier

Access to resources Recommend Favorite

Dibenzo[1,6]naphthyridindiones as modified quinolone antibacterials

By Cecchetti V.   Fravolini A.   Sabatini S.   Tabarrini O.   Xin T.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 11, 1998-11 ,pp. : 899-903

Elsevier

Access to resources Recommend Favorite

Transintestinal secretion of ciprofloxacin, grepafloxacin and sparfloxacin: in vitro and in situ inhibition studies

By Rodrguez-Ibanez M.   Nalda-Molina R.   Montalar-Montero M.   Bermejo M.V.   Merino V.   Garrigues T.M.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 55, Iss. 2, 2003-03 ,pp. : 241-246

Elsevier

Access to resources Recommend Favorite

Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration

By Patmore L.   Fraser S.   Mair D.   Templeton A.  

European Journal of Pharmacology, Vol. 406, Iss. 3, 2000-10 ,pp. : 449-452

Elsevier

Access to resources Recommend Favorite

Interactions between new quinolone antibacterials and diagnostic drug containing manganese

By Hosono Moeko   Yokoyama Haruko   Takayanagi Risa   Yamada Yasuhiko  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 38, Iss. 4, 2013-12 ,pp. : 255-259

Springer Publishing Company

Access to resources Recommend Favorite